Received Jul 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | 1 | y1a212m | LA |
Patient presented to the pharmacy verbally requesting a polio vaccine. Patient completed a vaccine consent form for the vaccine. Pharmacist verified polio vaccine (IPOL) in pharmacy system. Patient was checked out at pharmacy register for IPOL vaccine. At the pharmacy register patient verbally confirmed that she was to receive the polio vaccine. Patient was asked to step into the Pharmacy's vaccine administration area. At this time Pharmacist confirmed patient name and date of birth. Patient's consent form stated she was interested in receiving "Prolio". Pharmacist verbally confirmed with the patient that she was to receive the polio vaccine, and patient confirmed. Patient asked if the polio vaccine was for bones. Pharmacist stated that the polio vaccine was used to prevent polio. Patient mentioned that she believed the vaccine was to be administered in the abdomen. Pharmacist stated that the vaccine prepared, inactivated polio vaccine (IPOL), was to be administered intramuscularly in the deltoid muscle. Patient consented to the administration. Vaccine was administered intramuscularly in patient's left deltoid muscle. After administration, patient returned to the pharmacy stating she believed she received the wrong injection. After further questioning, patient was interested in Prolia injection. Patient was informed that she had received and polio vaccine and not a Prolia injection and to contact her physician for a Prolia prescription. Patient reported no other symptoms or side effects at this time.
Unknown
Unknown
Unknown
NKDA
n/a